BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10690341)

  • 1. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
    Wildhirt SM; Weismueller S; Schulze C; Conrad N; Kornberg A; Reichart B
    Cardiovasc Res; 1999 Aug; 43(3):698-711. PubMed ID: 10690341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion--implications for iNOS-mediated myocardial stunning.
    Wildhirt SM; Schulze C; Conrad N; Kornberg A; Horstman D; Reichart B
    Thorac Cardiovasc Surg; 1999 Jun; 47(3):137-43. PubMed ID: 10443512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
    Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
    J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.
    Wang D; Yang XP; Liu YH; Carretero OA; LaPointe MC
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):174-82. PubMed ID: 10090345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
    Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
    J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
    Imagawa J; Yellon DM; Baxter GF
    Br J Pharmacol; 1999 Feb; 126(3):701-8. PubMed ID: 10188982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase.
    Wang YP; Sato C; Mizoguchi K; Yamashita Y; Oe M; Maeta H
    Cardiovasc Res; 2002 Oct; 56(1):33-42. PubMed ID: 12237164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation.
    Yoshida T; Engelman RM; Engelman DT; Rousou JA; Maulik N; Sato M; Elliott GT; Das DK
    Ann Thorac Surg; 2000 Sep; 70(3):895-900. PubMed ID: 11016330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction.
    Wildhirt SM; Suzuki H; Horstman D; Weismüller S; Dudek RR; Akiyama K; Reichart B
    Circulation; 1997 Sep; 96(5):1616-23. PubMed ID: 9315556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats.
    Fu Y; Wang Z; Chen WL; Moore PK; Zhu YZ
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1545-52. PubMed ID: 17526656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
    Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
    Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
    Shi EY; Jiang XJ; Bai H; Nakajima Y
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats.
    Parlakpinar H; Ozer MK; Acet A
    Mol Cell Biochem; 2005 Sep; 277(1-2):137-42. PubMed ID: 16132725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice.
    Jiang X; Shi E; Nakajima Y; Sato S
    Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial ischemia/reperfusion injury in the inducible nitric oxide synthase knockout mice.
    Xi L; Jarrett NC; Hess ML; Kukreja RC
    Life Sci; 1999; 65(9):935-45. PubMed ID: 10465353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
    Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
    Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
    Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.